![Thomas Blaettler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Thomas Blaettler worked as the Chief Medical Officer at Orphazyme A from 2016 to 2021.
Prior to that, he was the Group Medical Director at F.
Hoffmann-La Roche Ltd. from 2009 to 2016.
Blaettler holds a doctorate degree from the University of Zurich.
Eerdere bekende functies van Thomas Blaettler
| Bedrijven | Functie | Einde |
|---|---|---|
| STRATEGIC PARTNERS A/S | Hoofd Techniek/Wetenschap/O&O | 01-10-2021 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-10-2016 |
Opleiding van Thomas Blaettler
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Kies MarketScreener 
